Highlights and Quick Summary
- Non-operating Income/Expense for the quarter ending December 31, 2022 was $-761 Thousand (a 851.25% increase compared to previous quarter)
- Year-over-year quarterly Non-operating Income/Expense decreased by -46.14%
- Annual Non-operating Income/Expense for 2022 was $-4.24 Million (a -77.71% decrease from previous year)
- Annual Non-operating Income/Expense for 2021 was $-19 Million (a 4.47% increase from previous year)
- Annual Non-operating Income/Expense for 2020 was $-18.2 Million (a 306.84% increase from previous year)
- Twelve month Non-operating Income/Expense ending December 31, 2022 was $-4.24 Million (a -51.02% decrease compared to previous quarter)
- Twelve month trailing Non-operating Income/Expense decreased by -73.87% year-over-year
Trailing Non-operating Income/Expense for the last four month:
31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
---|---|---|---|
$-4.24 Million | $-8.66 Million | $-13.4 Million | $-16.2 Million |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-operating Income/Expense of Precigen, Inc.
Most recent Non-operating Income/Expenseof PGEN including historical data for past 10 years.Interactive Chart of Non-operating Income/Expense of Precigen, Inc.
Precigen, Inc. Non-operating Income/Expense for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $-0.76 | $-0.08 | $-1.99 | $-1.41 | $-4.24 |
2021 | $-5.18 | $-4.85 | $-4.78 | $-4.21 | $-19.02 |
2020 | $-5.42 | $-4.58 | $-4.0 | $-4.21 | $-18.21 |
2019 | $3.58 | $-4.42 | $-0.94 | $-2.7 | $-4.48 |
2018 | $-2.58 | $-6.6 | $-18.22 | $1.16 | $-26.25 |
2017 | $1.18 | $3.09 | $14.8 | $-1.53 | $17.54 |
2016 | $-12.91 | $-1.61 | $-27.4 | $-27.07 | $-68.99 |
2015 | $1.33 | $-32.04 | $-23.13 | $113.72 | $59.89 |
2014 | $36.77 | $-38.82 | $-35.14 | $21.43 | $-15.76 |
2013 | $4.71 | $27.03 | $7.74 | $-22.36 | $17.12 |
2012 | $-4.01 | $4.71 | – | – | $-6.72 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology